Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat
Conclusion: This study confirmed that roxadustat therapy could alleviate the anemia of DD-CKD and NDD-CKD patients by raising the hemoglobin level and regulating iron metabolism, but increased serious incidences of treatment-emergent adverse events (TEAEs) in NDD-CKD patients.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Anemia | Aranesp | Chronic Kidney Disease | Clinical Trials | Databases & Libraries | Dialysis | Drugs & Pharmacology | Epogen | Iron | Procrit | Science | Study | Urology & Nephrology | Websites